Description: TASP0415914 is an orally potent phosphoinositide 3-kinase γ (PI3Kγ) inhibitor for the treatment of inflammatory diseases. It demonstrated good potency in a cell-based assay and exhibited in vivo efficacy in a collagen induced arthritis (CIA) model in mice after oral administration.